SEC Form 4/A · accession 0001104659-26-079319
ProQR Therapeutics N.V. · PRQR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Gylvin Lykke Hinsch
Director
Period of report
Jun 2, 2026
Accepted (ET)
Jun 30, 2026 · 4:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001612940
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F1,F2 | $1.42 | Jun 2, 2026 | A | 14,595 | A | — | Jun 1, 2036 | Ordinary Shares | 14,595 | 14,595 | D |
Explanation of responses
- F1The price reported in Column 2 is based upon the closing market price of the Issuer's ordinary shares on June 1, 2026, as determined pursuant to the Issuer's Board Compensation Policy.
- F225% of the shares subject to such option vest and become exercisable on June 2, 2027, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
Remarks
This Form 4/A amends the Form 4 filed on June 3, 2026 solely to correct the number of share options reported. No other information in the original Form 4 has been changed.